Perlara is a decentralized biotech company revolutionizing rare disease treatment. They develop repurposed drugs through innovative clinical trials and a predictive R&D engine, offering hope to families affected by rare diseases.
Perlara provides targeted medical solutions for rare diseases, focusing on precision medicine and innovative research.
Families with children affected by rare diseases, researchers and scientists in the medical field,
